Information Provided By: 
Fly News Breaks for August 18, 2017
THC
Aug 18, 2017 | 07:18 EDT
Leerink analyst Ana Gupte views the post-Q2 earnings selloff in shares of Tenet Healthcare as overdone. While the company experienced the same secular headwinds in the Hospital segment as its peers, the pricing growth was "solid" and the Ambulatory segment performed well with increased guidance, Gupte tells investors in a research note. She sees Tenet's ability to achieve earnings expectations as better than feared and keeps an Outperform rating on the name. Gupte dropped her price target for the shares to $23 from $27.
News For THC From the Last 2 Days
There are no results for your query THC
